-
The recent rally on Wall Street stalled yesterday as the initial momentum from the China-U.S. negotiations faded and concerns about sticky inflation resurfaced (S&P500: +0.1%, Nasdaq: +0.7%, DJIA: -0.2%, Russell 2000: -0.88%).
-
However, the U.S. AI initiative in Saudi Arabia continued to fuel euphoria in tech stocks (NVDA.US: +4.7%, AMD.US: +4.7%), while Boeing shares were supported by a large order from Qatar Airways (BA.US: +0.7%).
-
According to Fed’s Philip Jefferson, tariffs may still slow growth and add to current inflation levels, highlighting persistent uncertainty and the well-positioned nature of current U.S. interest rates.
-
The fading of the negotiation narrative triggered the first correction in five sessions across Asia-Pacific markets. Japan's Nikkei 225 fell (-0.9%), South Korea's Kospi dropped (-0.8%), and China's HSCEI declined (-0.75%).
-
The exception was Australia's S&P/ASX 200, which rose 0.2% after strong April labor market data. Employment grew by 89,000 (forecast: 22.5k, previous: 36.4k), while the unemployment rate remained unchanged at 4.1%. The participation rate also rose (from 66.8% to 67.1%).
-
On the forex market: the dollar is retreating against most G10 currencies (USDIDX: -0.13%). Safe haven currencies are rebounding, particularly the yen (USDJPY: -0.5%) and the Swiss franc (USDCHF: -0.25%). Meanwhile, antipodean currencies are depreciating (AUDUSD: -0.05%, NZDUSD: -0.12%). EURUSD is up 0.15% to 1.119.
-
Gold continues to fall (-1.4% to $3,132 per ounce), as does silver (-1.3% to $31.80 per ounce).
-
Brent and WTI crude oil are down about 2.55% following reports that Iran is willing to abandon its nuclear program development in exchange for the lifting of U.S. sanctions.
-
In the cryptocurrency market, broad pessimism persists (Bitcoin: -1.16%, Ethereum: -1.17%, Trump: -3.7%, Polygon: -3%, Chainlink: -2.5%, Solana: -2%).
Daily Summary: U.S. stock indices are climbing following the PPI data
AI needs power and that’s where the profits are. Oracle and Bloom set the path.
US OPEN: Wall Street Rallies on Soft PPI Data
Novo Nordisk announces a strategic partnership with OpenAI🧬🤖
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
